CORDOVACANN CORP (LVRLF) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2021, filed Dec 15, 2021. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LVRLF SEC filings page.
This page shows CORDOVACANN CORP (LVRLF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
CORDOVACANN CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
CORDOVACANN CORP reported -$2.6M in net income in fiscal year 2021.
Not reported for fiscal year 2021.
Not reported for fiscal year 2021.
Not reported for fiscal year 2021.
Cash & Balance Sheet
CORDOVACANN CORP held $1.1M in cash as of fiscal year 2021; long-term debt is not reported for that period.
Not reported for fiscal year 2021.
Not reported for fiscal year 2021.
Margins & Returns
None of these metrics is reported for fiscal year 2021.
Capital Allocation
None of these metrics is reported for fiscal year 2021.
LVRLF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2110-K |
|---|---|
| Income Tax | $315K |
| Net Income | -$2.6M |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
LVRLF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2110-K |
|---|---|
| Cash & Equivalents | $1.1M |
Not reported in any period shown, so not listed: Total Assets, Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Total Liabilities, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Total Equity, Retained Earnings.
Where CORDOVACANN CORP Ranks
Frequently Asked Questions
Is CORDOVACANN CORP profitable?
No, CORDOVACANN CORP (LVRLF) reported a net income of -$2.6M in fiscal year 2021.
What is CORDOVACANN CORP's P/E ratio?
CORDOVACANN CORP (LVRLF) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2021). The market capitalization is $2.4M as of Sep 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is CORDOVACANN CORP's price-to-sales ratio?
CORDOVACANN CORP (LVRLF) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $2.4M as of Sep 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.